Dr. David H. Harpole

I have the privilege of treating patients with both benign and malignant conditions of the chest. While in college at Georgia Tech, I envisioned a career as a biomedical engineer. What I quickly learned, however, was that I was more interested in patients and their medical problems than developing the technology to care for them. During my medical education and training, I learned not only how to become a surgeon, but also learned the value of teamwork and family in caring for patients. As a thoracic surgeon, one of the best and most important aspects of my job is being able to establish a relationship with my patients and their families, working together to help them through their illness. Dr. Tong is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Lung Nodules, Pleuropulmonary Blastoma, Vagotomy, and Advanced Bronchoscopy.

I graduated from Harvard University (BA) and the College of Physicians & Surgeons of Columbia University (MD). I received training in General Surgery and Thoracic Surgery at Duke University Medical Center. After completing a Fellowship in Thoracic Surgical Oncology at the Memorial Sloan-Kettering Cancer Center, I joined the faculty at Duke University Medical Center. I am currently Professor and Vice Chairman of Surgery, Chief of the Section of General Thoracic Surgery, Director of the Training Program in Thoracic Surgery, and Chief Medical Officer of the Duke Cancer Institute. I specialize in the surgical management of lung cancer and esophageal cancer, with a focus on minimally invasive thoracic surgery. As Vice Chair of Surgery, I am responsible for the development of technology and innovation in the Department. As Director of the Thoracic Oncology Program of the Duke Cancer Institute, I supervise the clinical and research programs in lung cancer and esophageal cancer. I am also involved in improving safety and quality in cancer care, as a member of the Duke Safety and Quality Committee. Dr. D'amico is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Lung Adenocarcinoma, Endoscopy, and Gastrectomy.

A significant portion of my practice involves advanced minimally invasive techniques in thoracic surgery to treat diseases such as lung or esophageal cancer. Another part of my clinical practice is spent taking care of patients with severe lung disease, especially those needing lung transplantation. Patients from all over the world come to Duke for lung transplantation. Research demonstrates that experience is very important in taking care of complex medical problems, both on the surgical side and on the medical side. We have one of the largest transplant centers in the world with excellent survival statistics, as well as the shortest wait list time. Instead of the national average which may be four to six months, our patients wait an average of about two weeks. One of the best aspects of being a patient or working at Duke is the people who work here. No matter how challenging the medical problems may be or what problems may arise, I know there’s a world’s expert a phone call away who can help intervene and I know that my patients will be cared for by committed Duke staff from across the hospital. Dr. Hartwig is rated as a Distinguished provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Hiatal Hernia, Thymic Epithelial Tumor, Endoscopy, and Heart Transplant.